Callan Family Office’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
Other funds holding ELAN
VPM
VCM
Callan Family Office's ELAN Position: Q1 2026 in Review
Callan Family Office reduced its Elanco Animal Health (ELAN) stake by 1.7% in Q1 2026, selling an estimated $70.2K and leaving 164,316 shares worth $3.93M. The position accounts for 0.09% of the portfolio, ranked #228.
Callan Family Office first reported a position in ELAN in Q1 2023 and has held it in 7 quarters since. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.
- Callan Family Office held 164,316 shares of Elanco Animal Health worth $3.93M as of Q1 2026.
- Callan Family Office sold 2,871 Elanco Animal Health shares in Q1 2026, an estimated $70.2K.
- Elanco Animal Health made up 0.09% of Callan Family Office's portfolio in Q1 2026, its #228 holding.
- Callan Family Office first reported a position in Elanco Animal Health in Q1 2023 and has held it in 7 quarters since.
- 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.
Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.